Shopping Cart
- Remove All
- Your shopping cart is currently empty
4-oxo Docosahexaenoic acid (4-oxo DHA) is a putative metabolite of DHA with antiproliferative and PPARγ agonist activity. It inhibits the growth of several triple-negative breast cancer cell lines [MCF-10F, trMCF, bsMCF, MDA-MB-231, and BT549] at 50-100 μM but increases the proliferation of MCF-7 cells. 4-oxo DHA binds covalently to PPARγ and activates gene transcription in luciferase reporter assays and dendritic cells with EC50 values of approximately 8-16 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg | $123 | 35 days | |
50 μg | $230 | 35 days | |
100 μg | $430 | 35 days | |
250 μg | $950 | 35 days |
Description | 4-oxo Docosahexaenoic acid (4-oxo DHA) is a putative metabolite of DHA with antiproliferative and PPARγ agonist activity. It inhibits the growth of several triple-negative breast cancer cell lines [MCF-10F, trMCF, bsMCF, MDA-MB-231, and BT549] at 50-100 μM but increases the proliferation of MCF-7 cells. 4-oxo DHA binds covalently to PPARγ and activates gene transcription in luciferase reporter assays and dendritic cells with EC50 values of approximately 8-16 μM. |
Molecular Weight | 342.479 |
Formula | C22H30O3 |
Cas No. | 845673-74-7 |
Relative Density. | 0.992 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | PBS (pH 7.2): 0.1 mg/mL DMF: 50 mg/mL DMSO: 50 mg/mL Ethanol: 50 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.